Filing Flows

Filing Flows › Lumexa Imaging Holdings (LMRI) › Q1 2026

Lumexa Imaging Holdings (LMRI) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 12, 2026

Lumexa Imaging Holdings (LMRI) reported revenue of $253M for the first quarter 2026 (Q1 2026), +3% from a year earlier. Operating margin was 7.7%, net earnings $1.7M (0.7% of revenue).

Revenue$253M
Year over year+3%
Quarter over quarter—
Operating margin7.7%
Net earnings$1.7M

Lumexa Imaging Holdings, Q1 2026: revenue $253M (+3% year over year), operating margin 7.7%, net earnings $1.7M, operating cash flow $2.9M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$253M—+3%
Operating profit$19.4M—-24%
Net earnings$1.7M——
Operating cash flow$2.9M——

What changed

Revenue was $252.5M in Q1 2026, up 3% year over year. Health Care Patient Service was the largest line at 75% of revenue. Health Care Patient Service added $4.8M year over year (up 3%), 63% of the total change.

Operating profit was $19.4M, a 7.7% margin (down 2.7 points year over year). Operating profit fell $6.1M even though revenue rose $7.5M versus a year earlier, so costs grew faster than sales. Total costs grew 6% against revenue growth of 3%. The fastest-growing cost line was General & admin (+16%). Net earnings were $1.7M. The effective tax rate was 44.3%.

Operating cash flow was $2.9M, 171% of net earnings. Non-cash charges added back $9.9M of depreciation and amortization and $12.3M of share-based compensation. Working capital and other items used $21.0M. Capital expenditures of $5.3M exceeded it, leaving free cash flow of −$2.4M.

Questions

What was Lumexa Imaging Holdings' revenue in the first quarter 2026?

Lumexa Imaging Holdings (LMRI) reported revenue of $253M for the first quarter 2026 (Q1 2026), +3% from a year earlier.

Was Lumexa Imaging Holdings profitable in the first quarter 2026?

Operating profit was $19.4M (7.7% of revenue) and net earnings $1.7M.

Open the interactive Sankey →

Source: Lumexa Imaging Holdings 10-Q on SEC EDGAR.